Cellular oxygen sensing need in CNS function: physiological and pathological implications
1 Karolinska Institute, Cellular and Molecular Biology, Stockholm,
Sweden
2 Edinger Institute, Frankfurt, Germany
3 Max Planck Institute for Molecular Physiology, Dortmund,
Germany
* Author for correspondence at address 1 (e-mail: till.acker{at}cmb.ki.se)
Accepted 6 May 2004
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
A significant advance in our understanding of the hypoxia response stems from the discovery of the hypoxia inducible factors (HIF), which act as key regulators of hypoxia-induced gene expression. Depending on the duration and severity of the oxygen deprivation, cellular oxygen-sensor responses activate a variety of short- and long-term energy saving and cellular protection mechanisms. Hypoxic adaptation encompasses an immediate depolarization block by changing potassium, sodium and chloride ion fluxes across the cellular membrane, a general inhibition of protein synthesis, and HIF-mediated upregulation of gene expression of enzymes or growth factors inducing angiogenesis, anaerobic glycolysis, cell survival or neural stem cell growth. However, sustained and prolonged activation of the HIF pathway may lead to a transition from neuroprotective to cell death responses. This is reflected by the dual features of the HIF system that include both anti- and proapoptotic components.
These various responses might be based on a range of oxygen-sensing signal cascades, including an isoform of the neutrophil NADPH oxidase, different electron carrier units of the mitochondrial chain such as a specialized mitochondrial, low PO2 affinity cytochrome c oxidase (aa3) and a subfamily of 2-oxoglutarate dependent dioxygenases termed HIF prolyl-hydroxylase (PHD) and HIF asparaginyl hydroxylase, known as factor-inhibiting HIF (FIH-1). Thus specific oxygen-sensing cascades, by means of their different oxygen sensitivities, cell-specific and subcellular localization, may help to tailor various adaptive responses according to differences in tissue oxygen availability.
Key words: glioblastoma, hypoxia inducible factor, HIF prolyl, hydroxylase, iron, ischemia, NADPH oxidase, mitochondria, mitochondriopathy, neurogenesis, neurodegenerative disease, oxygen sensing, preconditioning, reactive oxygen species, stem cell, tumor, VEGF
![]() |
Brain oxygen supply |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
Brain oxygen sensing need |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Disturbances in oxygen availability have been implicated in the central
nervous system (CNS) pathology of a number of disorders including stroke, head
trauma, neoplasia, vascular malformations and neurodegenerative diseases.
Thus, complex cellular oxygen-sensing systems have evolved to ensure tight
regulation of oxygen homeostasis in the brain to avoid metabolic compromise or
the risk of oxidation toxicity. These induce an elaborate sequence of adaptive
mechanisms in response to variations in PO2
designed to avoid or at least minimize brain damage, including short-term
(seconds, minutes) and long-term (hours, days) responses. Impressive examples
of brain oxygen-sensing systems under various physiological and pathological
conditions are described in the literature: tissue oxygenation is highly
dependent on the regulation of cerebral blood flow. By adjusting the vascular
tone, perfusion is kept constant over a wide range of blood pressures, a
process termed cerebral autoregulation. Autoregulation of cerebral blood flow
provides a powerful mechanism to counteract regional imbalances in oxygen
supply. Thus, increases in brain neural activity that lead to changes in
metabolic demand elicit an increase in local blood supply within the
corresponding brain region. This response is probably triggered by an `initial
dip' of tissue PO2 due to an increased oxygen
consumption, as elegantly shown on the visual cortex
(Thompson et al., 2003).
Neuronal activity and excitability can be directly regulated in response to
O2 availability by altering membrane channel conductivity. Central
neurons contain O2-sensitive potassium channels that are reversibly
inhibited by hypoxia (Jiang and Haddad,
1994
). These channels, partly identified as TASK channels, are
also regulated by a number of neurotransmitters, identifying them as key
players in oxygen-sensitive regulation of neuronal excitability
(Brickley et al., 2001
;
Maingret et al., 2001
).
Neonatal rats survive and avoid brain injury during periods of anoxia up to 25
times longer than adults, most likely due to a hypoxia-suppressed
N-methyl-D-aspartate receptor response to glutamate
excitotoxicity (Bickler et al.,
2003
). A further neuroprotective early response lies in the active
suppression of gene transcription (Denko
et al., 2003a
) and protein synthesis
(Hata et al., 2000
), leading
to a shut-down of non-essential energy-consuming mechanisms that are not
required for immediate cell survival, a process termed oxygen conformance (for
reviews, see Zhou et al.,
2004
; Hochachka and Lutz,
2001
). Suppression involves inhibiting assembly of the two main
regulators of translation initiation, namely eukaryotic initiation factor
(eIF) 4F (Martin et al.,
2000
,
2001
;
Arsham et al., 2003
) and eIF2
(Sullivan et al., 1999
;
Althausen et al., 2001
;
Martin et al., 2001
;
Koumenis et al., 2002
) and
inhibition of the eukaryotic elongation factor (eEF) 2
(Althausen et al., 2001
).
Reversible inhibition of translation has been reported to occur at
O2 levels between 0.5% and 1%
(Görlach et al., 2000
;
Lang et al., 2002
).
Beyond these short-term responses, adaptation to reduction in oxygen
availability necessitates changes in gene expression, which would be predicted
to lead to reduced oxygen consumption and increased oxygen delivery, and
provide a means of counteracting the detrimental effects of hypoxia and
reoxygenation. In particular, reoxygenation encountered after spontaneous or
thrombolytic reperfusion following vessel occlusion, for example, carries a
risk of accumulation of toxic ROS, as antioxidative defense mechanisms in the
cell are perturbed causing additional tissue damage. Specific redox-sensitive
transcription factor systems such as HIF, nuclear factor kB (NF-kB), activator
protein 1 (AP-1) and early growth response protein-1 (EGR-1), have been
described that respond to changes in PO2 or an
excess in ROS by activation of appropriate target gene expression
(Koong et al., 1994;
Yan et al., 1999
). The
identification of the HIF transcription system by Wang and Semenza
(1995
) was a milestone in our
understanding of oxygen physiology. Since then the HIF system has emerged as a
key regulatory system of responses to hypoxia at both local and systemic
levels. It is believed that approximately 11.5% of the genome is
transcriptionally regulated by hypoxia. However, significant heterogeneity in
the transcriptional response to hypoxia is observed between different cell
types (Denko et al.,
2003b
).
![]() |
The HIF transcriptional complex |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The HIF transcriptional system acts as a master regulator of
oxygen-regulated gene expression, inducing adaptive mechanisms that serve the
common purpose of maintaining oxygen homeostasis. To date more than 60
putative HIF-target genes have been identified, expression of which governs
important processes such as angiogenesis and regulation of vascular tone,
erythropoiesis, iron homeostasis, energy metabolism and pH regulation as well
as cell survival and proliferation (for a review, see
Semenza, 2003). The latter is
especially puzzling, as recent studies support the view that, apart from
inducing pro-proliferative proteins such as IGF-2, IGF-BP (binding proteins)
13 and TGF (transforming growth factor) ß3, the HIF pathway
includes responses with adverse effects on cell function by inducing
cell-cycle-arrest-specific and proapoptotic proteins such as DEC (defective
chorion)-1, BNIP (Bcl2/adenovirus E1B 19kD-interacting protein)-3, its
orthologue NIX (Nip3-like protein X) and cyclin G2. In addition, direct
stabilization of the proapoptotic protein p53 has been suggested by studies
demonstrating physical and functional interaction between HIF-1
and p53
(for a review, see Acker and Plate,
2002
). Thus, the HIF system transactivates an extended
physiological pathway that encompasses a wide array of physiological responses
to hypoxia, ranging from mechanisms that increase cell survival to those
inducing cell cycle arrest or even apoptosis. Given the range and diversity of
regulated cellular functions it is easy to predict that the HIF system is
likely to be crucially involved in many physiological and pathophysiological
processes within the brain. However, our current understanding of the role of
HIF in these processes is rather limited. Activation of pathways with
seemingly opposing functions on cell survival, e.g. inducing neuroprotection
or neuronal cell death, as outlined in Fig.
1, further complicates elucidation, pointing towards a more
complex and highly cell-context-dependent role of HIF.
|
![]() |
HIF in brain physiology and pathophysiology |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cerebral ischemia
The change in HIF-1 activity in response to reduction of
PO2 was analyzed in animal models of hypoxia,
global brain ischemia, focal ischemia and neonatal hypoxia/ischemia.
Widespread constitutive neuronal HIF-1
mRNA, protein and HIF-target
gene expression was reported in different regions of the brain, as shown in
Fig. 2 for the rat cerebral
cortex, which was found to further increase following hypoxic exposure
(Bergeron et al., 1999
;
Kietzmann et al., 2001
;
Chavez et al., 2000
;
Beck et al., 2000
).
Interestingly, HIF-1
translation is exempted from the overall
suppression of protein synthesis observed in hypoxic/ischemic conditions,
allowing for efficient and rapid protein accumulation
(Görlach et al., 2000
;
Lang et al., 2002
).
|
The precise role of HIF-2 in the brain following a reduction in
PO2 remains elusive. One report demonstrated
induction of HIF-2
mRNA in endothelial cells following focal cerebral
ischemia (Marti et al.,
2000
). However, two studies using different methods to reduce
oxygen availability demonstrated differential regulation of HIF-1
and
HIF-2
subunits according to the experimental conditions and cell type,
suggesting vital non-redundant functions of both isoforms, and warranting
further analysis (Stroka et al.,
2001
; Wiesener et al.,
2003
).
Concomitant induction of adaptive mechanisms such as glycolytic metabolism
and angiogenesis following hypoxia/ischemia further supports a neuroprotective
role of HIF activation. Subjecting animals to a brief and moderate episode of
hypoxia/ischemia elicits an autoprotective response, which results in
protection against a subsequent prolonged ischemic event, a phenomenon termed
preconditioning (for a review, see Dirnagl
et al., 2003). Preconditioning is likely to involve adaptive
changes in gene expression to activate the endogenous protective mechanism, as
it generally takes several hours to days after a preconditioning episode to
attain a state of tolerance. Preconditioning studies have identified a subset
of neuronal transcripts regulating a number of adaptive processes, including
ROS inactivation, metabolic switch, angiogenesis and neuroprotective
paracrine-acting factors involving known HIF target genes. In particular the
hypoxia-inducible gene products Epo (erythropoietin) and VEGF (vascular
endothelial growth factor), which are commonly expressed by neurons and
astrocytes (Bernaudin et al.,
2002
; Beck et al.,
2000
) have been identified as potential mediators of hypoxic
preconditioning (Bernaudin et al.,
1999
; Prass et al.,
2003
; Wick et al.,
2002
). Interestingly, hypoxic preconditioning has been found to
increase HIF-1
expression and can also be achieved by known chemical
inducers of HIF-
such as CoCl2 and desferrioxamine,
suggesting that the preconditioning phenomenon is mediated by HIF-activity
(Prass et al., 2002
;
Bergeron et al., 2000
). In
contrast, studies on neonatal mouse cortices revealed that inhibition of
HIF-activity using a dominant negative HIF-1
mutant protected cortical
neurons from delayed cell death following oxygen and glucose deprivation
(Halterman et al., 1999
). The
results are consistent with a model in which HIF-1
-mediated p53
stabilization promotes neuronal cell death following an ischemic exposure.
Thus, the important question of the role of HIF activation in determining
the outcome of ischemic and oxidative injury may be more difficult to answer
than expected, though essential to a future therapeutic application of HIF
activators or inhibitors. The severity and duration of hypoxia, protein levels
and phosphorylation status of HIF- subunits may be decisive parameters
in governing these fundamentally different responses on cell fate, mediating
the transition from adaptive neuroprotective to cell death responses
(Fig. 1; Piret et al., 2002
;
Carmeliet et al., 1998
).
Interestingly, VEGF with its pleiotropic effects stimulating angiogenesis and
vascular permeability as well as exerting direct neuroprotective activities,
reveals a similar diverse outcome on cell survival
(Carmeliet and Storkebaum,
2002
). It is worth remembering that HIF-regulated prosurvival or
proapoptotic processes in response to ischemia and oxidative stress reflect
common pathophysiological components that are probably shared by many
neuropathological diseases (see below) as, for example, suggested in multiple
sclerosis, an inflammatory, demeyelinating brain lesion
(Aboul-Enein et al., 2003
).
Neurogenesis
Recent years have opened an interesting new door with the potential of
restoring and replenishing injured tissue. It is well known that cells are
continuously replaced in various organ systems in the body throughout life.
The CNS has been traditionally viewed for many decades as a system with very
limited capacity for self-renewal and regeneration. This dogma is, however,
challenged by a growing body of evidence supporting the concept that, in
certain brain regions, neural stem cells exist that give rise to new neurons
as part of a general endogenous turnover mechanism, as well as in response to
injury (reviewed by Doetsch,
2003). Various factors that influence neural stem cell function
have subsequently been identified. A number of recent studies suggest that
oxygen-dependent gene expression is of crucial importance in governing
essential steps of neurogenesis such as cell proliferation and renewal,
survival and differentiation. Indirect evidence for this stems from studies
demonstrating increased cell proliferation and neurogenesis after
hypoxic/ischemic episodes (Liu et al.,
1998
; Takagi et al.,
1999
; Jin et al.,
2001
). Low oxygen concentrations have been shown in in
vitro neurosphere assays to induce proliferation, cell survival and
neuronal differentiation (Studer et al.,
2000
; Morrison et al.,
2000
; Shingo et al.,
2001
). Accordingly, a number of hypoxia-inducible growth factors
such as VEGF, Epo, IGF-1 and stem cell growth factor have been implicated as
important regulators of neurogenesis (Jin et al.,
2002a
,b
;
Shingo et al., 2001
;
Aberg et al., 2000
). So far no
studies on HIF-
function in neural stem cells have been performed, but
analysis of the effects of HIF-1
loss of function in other organ
systems suggests a pivotal role in stem cell homeostasis
(Schipani et al., 2001
;
Seagroves et al., 2003
).
Interestingly, the redox state of the cell seems to decisively influence cell
fate decision, either supporting self renewal (reduced state) or
differentiation (oxidized state) mechanisms
(Noble et al., 2003
). In
support of this concept, hypoxia has been shown to induce and keep cells in an
undifferentiated, immature phenotype (Jogi
et al., 2002
). Recent studies have highlighted the endogenous
repair capacity of the brain following injury after focal cerebral ischemia
and the potential for using these inherent regenerative abilities in putative
therapeutic approaches. Considerable regeneration of neurons from the
endogenous neural stem niche occurs within the striatum
(Arvidsson et al., 2002
).
Hippocampal regeneration by pyramidal cell replenishment can be even further
enhanced by ventricular application of growth factors known to stimulate
neural stem cell growth (Nakatomi et al.,
2002
). A recent study elegantly exploited the pleiotropic and
possibly synergistically acting activities of VEGF to show that
intracerebroventricular VEGF application administered after the insult reduced
infarct size and improved the overall functional outcome, presumably as a
result of enhanced angiogenesis, neuroprotection and neurogenesis
(Sun et al., 2003
). Thus,
hypoxia-inducible gene expression may provide crucial cues to stimulate and
direct neurogenesis to areas where cells are lost.
Neurodegenerative disease
Neurodegenerative diseases as diverse as Alzheimer's disease,
frontotemporal dementia, prion diseases, Parkinson's disease, Huntington's
disease or amyotrophic lateral sclerosis are associated with the accumulation
of potentially toxic, aggregation-prone misfolded proteins
(Taylor et al., 2002).
Features of these diseases can be recapitulated in transgenic mouse models
overexpressing mutant proteins (Wong et
al., 2002
). Increasing evidence suggests that such protein
assemblies are particularly vulnerable to neurons by triggering cellular and
neuroinflammatory stress responses. Among others, oxidative stress in
particular has been implicated as a causative agent of progressing neuronal
degeneration.
Deposition of ß-amyloid (ßA) peptide, typically present in
extracellular plaques, is thought to be intimately connected to the initiation
of Alzheimer's disease (Bishop et al.,
2002). ßA peptides are believed to act as the primary toxic
agent detrimental to neural cell function and responsible for neural cell
death. They have been shown to directly induce ROS generation, thus causing
oxidative damage. A recent study implicated HIF-1
activation as a
general neuroprotective mechanism against oxidative stress and
ßA-toxicity (Soucek et al.,
2003
). Clonal neural cell lines and primary cortical neurons,
which are resistant to ßA-toxicity, revealed an enhanced flux of glucose
through the glycolytic and the pentose-phosphate pathway, due to enhanced
enzymatic activity. Based on this observation the authors went on to show that
this increase in cellular glucose metabolism correlated with elevated
HIF-1
protein levels and activity. Importantly, exposure of neurons to
ßA-peptide was shown to induce HIF-1
, though the mechanisms of
induction remained unknown. Interestingly, HIF controls the coordinate
upregulation of genes of the glycolytic pathway, ranging from glucose uptake
to lactate production. HIF-mediated induction of glucose transport and
utilization has been implicated in supporting antioxidative mechanisms, by
generating reducing equivalents in the form of NADH and NADPH via
glycolysis or the pentose-phosphate pathway, as well as synthesis of the
antioxidant pyruvate. Thus, in Alzheimer's disease pathology, HIF may be
involved a feedback mechanism, whereby ßA induces HIF-1
activity,
which in turn upregulates adaptive antioxidative mechanisms to help to combat
the increased oxidative stress inflicted by ßA. Considering the growing
body of evidence that ROS regulate HIF activity (see below), an interesting
question remaining to be answered is whether ßA-mediated HIF induction
operates via ROS generation. This early neuroprotective response
induced by ßA may eventually be overridden by cumulative toxicity
effects. The neuron may finally succumb to the continuous stress afflicted by
neurotoxic peptides such as ß-amyloid and induce a cell death program.
Again, given the pro-apoptotic activity of HIF-1
, it is intriguing to
ask to what extent a ßA-mediated sustained and prolonged neural induction
of HIF-1
may participate in this process.
Amyotrophic lateral sclerosis, a progressive motorneuron disease, is
another intriguing example of implicating dysregulated oxygen signaling
pathways in the pathogenesis of neurodegenerative diseases. Motor neurons are
known to be exquisitely susceptible to variations of oxygen concentration.
Hence during transient episodes of ischemia the decrease in oxygen supply or
the oxidative damage caused by free radicals generated during reoxygenation
may prove particularly fatal. Indeed, cumulative oxidative damage due to the
toxic gain-of-function of mutant SOD1 has been linked to the pathogenesis of
amyotrophic lateral sclerosis (ALS;
Cluskey and Ramsden, 2001;
Rakhit et al., 2002
). A novel
player in the aetiology of ALS has only recently been identified. To study the
relevance of HIF-mediated induction of the VEGF-gene, transgenic mice with the
hypoxia-responsive element (HRE) deleted were generated
(Oosthuyse et al., 2001
).
HRE-deficiency was associated with a decrease in both normoxic baseline and
hypoxia-induced VEGF levels in the central nervous system, which predisposed
the animals to develop an adult-onset, progressive motor neuron disease. Motor
neuron loss in these mice probably resulted from a chronic reduction in neural
vascular perfusion, which in addition may have been exacerbated by an
insufficient VEGF-dependent neuroprotection. These findings prompted the
authors in a recent report to further analyze the contribution of impaired
VEGF regulation in the pathogenesis of human ALS
(Lambrechts et al., 2003
).
Interestingly, decreased VEGF protein serum levels were found in all ALS
patients analyzed, which in a subset of patients could be genetically linked
to specific haplotypes within the VEGF promotor/leader sequence being
associated with a reduced transcription, IRES-mediated expression and
translation of VEGF. These data also clearly implicate impaired VEGF
expression as a modulator of ALS pathology in the human situation. No sequence
variations in the HIF-binding site of the VEGF-promotor or functionally
relevant missense mutations in the HIF-1
and HIF-2
genes could
be identified.
Collectively, these studies implicate reduced hypoxia-induced expression of
genes with neurotrophic or neuroprotective effects as novel components in the
pathogenesis of neurodegenerative diseases. In addition, vascular defects and
chronic vascular perfusion deficits, e.g. chronic ischemia, have been
documented in a number of neurodegenerative conditions such as Alzheimer's
disease, Parkinson's disease or ALS (for a review, see
Storkebaum and Carmeliet,
2004). It remains to be elucidated whether and to what extent the
HIF-system may participate in the disease process. Current data would support
a dual, seemingly paradoxical role of the HIF-system, depending on whether it
is the cause or the consequence, i.e. a primary or secondary effect. Again the
opposing effects on cell survival of downstream components of the HIF complex
may be the clue to this paradox (Fig.
1). Impaired activation of the HIF-system would result in reduced
induction of neurotrophic adaptive cascades and thus decreased cell survival.
Support for this notion stems from studies showing that aging, a known risk
factor for neurodegenerative diseases such as Alzheimer's disease, severely
attenuates the capacity to induce HIF-1
activity, thus impairing the
cell's ability to respond adequately to ischemic stress
(Chavez and LaManna, 2003
). On
the other hand, chronic and sustained activation of the HIF-system as a
consequence of chronic vascular insufficiency, for example, may end in cell
degeneration. Interestingly, cellular disturbances of proteosomal function
resulting in ubiquitin accumulation have been reported in many
neurodegenerative disorders and are likely also to affect HIF-
levels
(Bence et al., 2001
). Both
pathomechanisms could even be operative in the same disorder, with the former
contributing to early-stage and the latter to late-stage disease process.
Considering the complexity of neurodegenerative disorders, however, the
process outlined above is likely to be oversimplified and warrants further
analysis. Transgenic animal studies selectively modulating HIF-1
and
HIF-2
expression and function in the different cell types of the brain
may be crucial in further clarifying the role of the HIF system in
neurodegeneration.
Neoplasia
Regions of low oxygen tension are commonly found in malignant tumors and
are associated with increased frequency of tumor invasion and metastasis and a
poor therapy outcome. The ability to initiate homeostatic responses and adapt
to hypoxia represents an important and crucial aspect in solid tumor growth.
In particular, activation of the HIF system has been identified as an
important mediator of these processes. The involvement of HIF in tumor
physiology is covered in more detail in a recent review
(Acker and Plate, 2002). In
comparison to adjacent tissue widespread HIF activation is observed in tumors,
correlating with tumor growth and progression. HIF overexpression in tumors is
related to both hypoxia-dependent (observed close to the necrotic area, as
shown in Fig. 2) and
hypoxia-independent mechanisms, such as oncogene activation and growth factor
signaling pathways. The relevance of the HIF system to tumor growth and
progression is highlighted by the variety of mechanisms regulated by
HIF-target genes, ranging from angiogenesis, to increase tissue oxygenation
over glycolysis, and pH regulation, allowing for energy generation when oxygen
is scarce, to cell proliferation and survival pathways. It is worth
remembering that the HIF pathway exerts its effects not only on the tumor cell
but also on the stromal microenvironment, to enhance and promote tumor
vascularization and growth. In fact, the activation of the HIF system elicits
a cellular and molecular crosstalk leading to the coordinated collaboration
between tumor, endothelial, inflammatory/hematopoietic and circulating
endothelial precursor cells (reviewed by
Acker and Plate, 2003
).
The clinical correlation between intratumoral hypoxia and tumor
aggressiveness, which is particularly characterized by tumor invasion and the
ability to metastasize, has found a possible molecular correlate in recent
studies. Thus, crucial steps in these processes, including cell mobility and
migration, tissue invasion and the ability to home into specific organ sites,
are governed by specific signaling pathways known to contain HIF-target genes
such as c-Met, the receptor for HGF (scatter factor/hepatocyte growth factor),
or the chemokine receptor CXCR4
(Pennacchietti et al., 2003;
Schioppa et al., 2003
;
Staller et al., 2003
). Both
receptor systems have well established functions in tumor invasion and
metastasis, as shown e.g. in breast cancer
(Muller et al., 2001
) or
gliomas (reviewed in Lamszus et al.,
1999
). In addition, several factors known to determine the
invasive cancer phenotype such as cathepsin D, matrix metalloproteinase 2 and
urokinase plasminogen activator receptor (uPAR) have been shown to be
regulated by HIF (Krishnamachary et al.,
2003
). Indeed, inhibition of the HIF pathway by geldanamycin was
shown to diminish glioma cell migration in vitro
(Zagzag et al., 2003
).
Interestingly, though a growing body of evidence suggests that HIF-1
is
the major orthologue to convey hypoxia-induced gene expression, both
HIF-1
and HIF-2
seem to be required for hypoxia-induced cell
migration, as shown recently by siRNA-mediated knock-down of each orthologue
in breast cancer cell lines (Sowter et
al., 2003
). Thus, low PO2 and
activation of the HIF system causes the tumor cell to migrate away from
hypoxic areas and invade further into the host tissue and organs, thus
supporting tumor spread. It is interesting to note that in highly invasive
glioblastoma multiforme, the most malignant and particular hypoxic brain tumor
entity, single tumor cells with high-level HIF expression have been detected
at the leading tumor invasion front
(Zagzag et al., 2000
).
Recent insight into the precise mechanisms of oxygen sensing and signaling
may help to develop novel anti-tumor strategies that specifically target the
PHD-HIF-VHL pathway. Given the widespread HIF activation in tumors, the role
of HIF in transactivating angiogenic factors and the role of angiogenic
factors in tumor growth, interfering with this pathway is particularly
appealing. Its rationale lies in depriving the tumor cell of oxygen and
nutrients by inhibiting angiogenesis while at the same time disabling adaptive
mechanisms that help the cell to survive in this microenvironment. The
feasibility of this approach has been confirmed in different reports
(Maxwell et al., 1997;
Ryan et al., 1998
;
Kung et al., 2000
;
Kim et al., 2001
). However,
given their key regulatory role in various complex physiological pathways
stretching from metabolism, proliferation and differentiation to apoptosis,
general manipulation of the HIF system is likely to show a variable outcome
depending on the cellular context, e.g. tumor cell type
(Carmeliet et al., 1998
;
Blancher et al., 2000
) or
tumor microenvironment (Blouw et al.,
2003
) and should for this reason be employed cautiously. HIF
itself may directly influence the outcome of present therapies such as
chemotherapy and radiotherapy. HIF-1
deficiency in fibroblasts resulted
in increased apoptotic cell death in response to agents such as carboplatin
and ectoposide or ionizing radiation known to induce double-strand breaks,
suggesting that HIF-1
may induce expression of genes involved in the
repair of DNA double-strand breaks (Unruh
et al., 2003
).
Manipulation of the putative oxygen sensor system prolyl hydroxylase (PHD;
see below) offers yet another new and challenging strategy to analyze and
influence tumor biology. Interestingly, PHD activity in cancer cells may be
reduced, as suggested by incomplete prolyl hydroxylation of HIF- in
normoxic tissue culture as detected by hydroxylation-specific antibodies
(Chan et al., 2002
).
HIF-
degradation under these conditions can be enhanced by vitamin C or
iron supplementation (Knowles et al.,
2003
), both important cofactors of PHD, suggesting that attenuated
PHD activity may contribute to the general HIF activation in tumor cells. In
line with these observations, ectopic PHD1 overexpression in colon carcinoma
cells suppressed HIF-1
levels and reduced in vivo tumor growth
(Erez et al., 2003
).
![]() |
Putative oxygen sensors |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
Oxygen-sensing heme proteins
Molecules changing their chemical properties as a direct consequence of the
surrounding PO2 may mediate the first step in
oxygen sensing. As for the carotid body, hypoxia leads to an increase in
afferent carotid sinus nerve activity, stimulating ventilation and blood
circulation in the body to avoid hypoxic tissue damage. The primary oxygen
sensor triggering this increase is as yet unknown, but there is large
agreement that it is a heme protein, either a mitochondrial component of the
respiratory chain (Baysal et al.,
2000; Mills and Jöbsis,
1972
; Wilson et al.,
1994
) or a non-mitochondrial protein like the NAPH oxidase (Nox;
Fu et al., 2000
;
Cross et al., 1990
).
Light absorption spectra identified very recently a cytochrome
a592 (shown in yellow in
Fig. 4) as a unique component
of carotid body cytochrome c oxidase. In contrast to other
cytochromes, cytochrome a592 revealed an apparent low
PO2 and high CN affinity,
probably due to a shortcut of electron flow within the cytochrome c
oxidase between CuA and cytochrome
a3CuB. It was suggested that this specific property
would allow the regulation of intracellular calcium levels under hypoxia
(Streller et al., 2002).
|
Furthermore, it was postulated that a NADPH oxidase isoform (shown in dark
green in Fig. 4) within carotid
body type I cell functions as an oxygen sensor to regulate ion channel
conductivity and gene expression (Cross et
al., 1990). In this context, various NADPH oxidase isoforms
comprising complexes between p22phox, gp91phox, p47phox, p40phox, p67phox and
Rac1, 2 components must be considered. Their function may not, however, be
limited to the carotid body, as they show widespread expression throughout the
body, e.g. Nox1 in pulmonary vasculature smooth muscle cells
(Weissmann et al., 2000
) or
the neutrophil Nox2 in endothelial cells
(Görlach et al., 2000b
)
and neuroepithelial bodies (NEB; Fu et
al., 2000
). The isoforms (Nox14 and the Duox group) make
use of the gp91phox component, as reviewed by Lambeth et al.
(2000
). Gp91phox knock-out
mice showed an impaired hypoxic ventilatory control in neonatal animals due to
a decreased oxygen sensitivity of NEB potassium channel conductivity
(Kazemian et al., 2001
;
Fu et al., 2000
) indicating an
oxygen sensor function of the NADPH oxidase in this cell type and related
strains (O'Kelly et al.,
2001
,
2000
). On the other hand,
gp91phox knock-out mice showed unimpaired oxygen-sensing function of pulmonary
vasculature smooth muscle cells (Archer et
al., 1999
) or carotid body hypoxic drive
(Roy et al., 2000
). However,
p47phox knock-out mice demonstrated an enhanced carotid body hypoxic drive,
suggesting a particular Nox isoform for the carotid body
(Sanders et al., 2002
). Taken
together, various NADPH oxidase isoforms may act as part of the oxygen-sensing
system.
Prolyl hydroxylases
Hydroxylation provides a dual mechanism of inhibiting HIF activity,
inducing proteolytic degradation and reducing transcriptional capacity. These
processes are conferred by a recently identified subclass of 2-oxoglutarate
dependent hydroxylases. Interaction of VHL with HIF- requires an
O2- and iron-dependent hydroxylation of specific prolyl residues
(Pro 402, Pro 564) within the HIF-
ODD (oxygen-dependent-domain)
carried out by HIF-prolyl hydroxylase (PHD;
Epstein et al., 2001
;
Bruick and McKnight, 2001
;
Oehme et al., 2002
). So far,
four orthologues of PHD have been described (PHD IIV). A second
oxygen-dependent switch involves hydroxylation of an asparagine residue within
the C-TAD of HIF-
subunits by a recently identified HIF asparaginyl
hydroxylase called factor-inhibiting HIF (FIH-1;
Lando et al., 2002
).
Asparagine hydroxylation apparently interferes with recruitment of the
coactivator p300, resulting in reduced transcriptional activity. Both PHD and
FIH belong to a superfamily of 2-oxoglutarate dependent hydroxylases, which
employ non-haem iron in the catalytic moiety
(Hewitson et al., 2002
). They
require oxygen in the form of dioxygen, with one oxygen atom being
incorporated in the prolyl or asparagyl residue, respectively, and the other
into 2-oxoglutarate, yielding succinate and CO2. Thus, the
hydroxylation reaction is inherently dependent on ambient oxygen pressure,
providing a molecular basis for the oxygen-sensing function of these
enzymes.
Interestingly, PHD are strikingly sensitive to graded levels of oxygen
in vitro, mirroring the progressive increase in HIF- protein
stability and transactivation activity observed when cells are subjected to
graded hypoxia in vitro (Epstein
et al., 2001
). In line with this observation, PHD have been found
to have a striking low O2 affinity of 178 mmHg above the
concentration of dissolved O2 in the air
(Hirsilä et al., 2003
).
Consequently, taking the regular tissue PO2
distribution as shown in the lower part of
Fig. 3, PHD would operate under
suboptimal, non-equilibrium conditions for HIF-
turnover far beyond
their Km. However, given regular MichaelisMenten
kinetics, this would allow the enzymes to operate in a highly sensitive
manner, in which small changes in oxygen concentration result in pronounced
changes in enzymatic reaction velocity and thus HIF-
turnover. In
contrast, collagen prolyl-4-hydroxylases exhibit a Km of
about 28 mmHg, one sixth of the Km of PHD, allowing
optimal hyroxyprolyl-collagen biosynthesis under the low oxygen concentrations
physiologically found in the cell
(Hirsilä et al., 2003
).
Recently, FIH was shown to have a Km of around 64 mmHg,
suggesting that this enzyme also acts as a bona fide oxygen sensor,
at least under conditions as found in normoxic tissues in vivo
(Linke et al., 2004
).
Immunohistochemical staining of tissues for HIF-
subunits is an
indirect method of assessing the activity of the PHD/HIF system in
vivo, and such studies have documented that HIF-
levels are
generally low in rodent tissues under physiological conditions and are
substantially increased in response to systemic hypoxia or tissue ischemia
(Stroka et al., 2001
;
Wiesener et al., 2003
).
Interestingly, HIF-
levels remain low even in regions such as the renal
medulla, which are characterized by low oxygen tensions known to enhance
HIF-
protein in vitro. In addition, the extent and time course
of induction as well as cell-type-specific expression varies, suggesting that
individual, cell-specific thresholds for activation of the response may exist.
The above mentioned characteristics of the PHD system render it highly
sensitive to alterations of cofactor concentration, such as ferrous iron
(Knowles et al., 2003
) or
2-oxoglutarate, substrate concentration, e.g. due to changes in HIF-
synthesis (Wiener et al.,
1996
; Zhong et al.,
2000
), as well as enzyme concentration, e.g. due to changes in
mRNA expression of PHD orthologues in response to
PO2
(Epstein et al., 2001
), being
particularly striking for PHD3 (del Peso
et al., 2003
). Consistent with this hypothesis, physiological
concentrations of cofactors such as ascorbate (2550 µmol
l1; Knowles et al.,
2003
) have been reported to be far below the
Km values of PHD for vitamin C (140170 µmol
l1; Hirsilä et al.,
2003
), suggesting significant alterations in PHD activity with
changes in cofactor concentrations, as outlined in
Fig. 3A. Our understanding of
the exact interplay of these factors in setting the sensitivity of the PHD/HIF
system is still incomplete, but nevertheless of crucial importance to
understanding the cell- and tissue-specific activity and response of the
oxygen-signaling cascade.
Interestingly, although ubiquitously expressed in various tissues, PHD
orthologues differ in their relative cell-specific abundance of mRNA levels
(Lieb et al., 2002;
Cioffi et al., 2003
;
Oehme et al., 2002
).
Moreover, PHD2 and PHD3 expression is upregulated by hypoxia, though the
fold-induction apparently varies between cell type and
PO2 analyzed
(Epstein et al., 2001
;
D'Angelo et al., 2003
;
del Peso et al., 2003
;
Berra et al., 2003
;
Metzen et al., 2003
). The
exact role of four PHD orthologues in the regulation of HIF activity remains
elusive. However, it is evident that the hydroxylation efficiency among PHD1-3
is not identical and in particular differs regarding HIF-
orthologue
preference and prolyl hydroxylation pattern, favoring the C-terminal prolyl
residue (Hirsilä et al.,
2003
). RNAi (RNA interference)-mediated knock-down studies suggest
that PHD2 is the rate-limiting enzyme controlling the steady state levels of
HIF-1
in normoxia, at least under cell culture conditions
(Berra et al., 2003
).
Moreover, the study implicated PHD2 in the initial stages of HIF-1
degradation following reoxygenation. Interestingly, a role for PHD1 in
controlling HIF-1
levels under long-term maintenance of hypoxia
(56 days) was proposed, suggesting further non-redundant functions of
each PHD orthologue in other physiological or pathophysiological settings.
The subcellular localization of PHD has been studied by ectopic expression
of chimeric EGFP-fusion proteins and three-dimensional two-photon confocal
laser scanning microscopy (2P-CLSM) analysis
(Metzen et al., 2003). PHD1
was detectable exclusively in the nucleus, PHD3 was distributed more evenly in
cytoplasm and nucleus, while the majority of PHD2 and FIH-1 was found in the
cytoplasm (Fig. 5). The latter
result is of interest because PHD2 and FIH-1 have a calculated molecular mass
of 46 kD and 40.3 kD, respectively. As molecules of up to 60 kD usually have
free access to the nuclear compartment, PHD2 and FIH-1 would be expected to be
present in cytoplasm and nucleus. This finding may suggest that PHD2 and FIH-1
are actively excluded from the nucleus.
|
Little is known about the involvement of PHD in pathological settings such
as neoplasia or neurological disorders. However, PHD may be a target of growth
factor signaling pathways and/or oncogenic transformation. In fact, it has
been shown that certain oncogenes such as ras and src induce HIF under
normoxia by inhibiting prolyl hydroxylation on Pro 564
(Chan et al., 2002). Recent
findings, however, suggest a possible link between PHD function and
tumorigenesis and neurodegeneration. The cosubstrate 2-oxoglutarate as an
intermediate of the Krebs cycle is generated in mitochondria. The two
ubiquitously expressed mitochondrial enzymes, succinate dehydrogenase (SDH)
and fumarate hydratase (FH), catalyze sequential steps in the Krebs cycle.
Interestingly, germline heterozygous mutations in the autosomally encoded
enzyme and enzyme subunits are associated with hereditary predispositions to
various tumors including paraganglioma, pheochromocytoma, benign smooth muscle
cell tumor and RCC (Tomlinson et al.,
2002
; Baysal et al.,
2000
; Niemann and Muller,
2000
; Astuti et al.,
2001
). Thus, both SDH and FH act as tumor suppressor genes. In
contrast, homozygous germline mutations in SDH subunits cause
mitochondriopathies such as the Leigh syndrome, which affect the central
nervous system and skeletal muscles. The underlying mechanism through which
loss of function leads to neoplasia or neurodegeneration remains unclear (for
a review, see Eng et al.,
2003
). It is nevertheless tempting to speculate that defects in
the Krebs cycle are likely to influence 2-oxoglutarate levels or other
metabolic intermediates compromising PHD function. Further mitochondrial
dysfunction may lead to increased production of ROS which, as described below,
may also signal on the PHD/HIF system. Interestingly, ROS itself have been
shown to interfere with mitochondrial function at the level of
-ketoglutarate dehydrogenase (KGDH) and SDH
(Nulton-Persson and Szweda,
2001
).
![]() |
Synopsis of oxygen sensing |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
Oxygen sensing heme proteins
The mitochondrial chain is a classical high affinity system keeping the
electron flux across the cytochrome c oxidase constant below
PO2 values of 1 mmHg
(Arthur et al., 1999).
Consequently, the tissue PO2 range covered by
the oxygen-sensing mitochondrial chain is small. However, with the mutated
cytochrome a592 an affinity modulator was proposed,
lowering the high PO2 affinity of cytochrome
c oxidase to about 30 mmHg
(Streller et al., 2002
).
NAD(P)H oxidase with a PO2 affinity of about 20
mmHg seems to be the main ROS donor in many cell systems
(Jones et al., 2000
). The low
Km of the NAD(P)H oxidase implies that it may function as
an oxygen sensor operating at low to intermediate
PO2 ranges. Interestingly, NADPH-activity is
exquisitely controlled by rac proteins and various growth factors
(Görlach et al.,
2003
).
Prolyl hydroxylases
In contrast, PHD have a strikingly low PO2
affinity above 150 mmHg (Hirsilä et
al., 2003), far beyond the regular tissue
PO2 distribution, allowing efficient regulation
of HIF activity under these conditions (see above). Apart from
PO2, PHD activity is regulated by the amount of
ferrous iron (reduced form) recovered by antioxidants such as vitamin C
(Knowles et al., 2003
). Iron
is required for heme formation, being the most common limiting factor for
erythropoiesis. Interestingly, HIF-target genes regulate different steps in
iron homeostasis from iron uptake to iron transport and iron storage
(Rolfs et al., 1997
;
Tacchini et al., 1999
;
Lok and Ponka, 1999
;
Mukhopadhyay et al., 2000
).
The implication of iron in oxygen sensing by 2-oxoglutarate-dependent
hydroxylases and the involvement of iron in oxygen toxicity through the Fenton
reaction (Porwol et al.,
2001
) give an additional need for tight iron regulation, making
the interaction between oxygen and iron homeostasis physiologically highly
appropriate. A further level of complexity is added as decreasing
O2 concentrations lower PHD activity which, however, may be
partially compensated for by the increased availability of ferrous iron due to
the more reduced state of the cell. Thus, the interplay is rather intricate to
understand and study, and activity of the PHD/HIF system likely to be
influenced by the redox state of the cell. Indeed, HIF is regulated in an
iron- and redox-sensitive fashion. Redox regulatory systems such as
Thioredoxin or Ref-1 have been shown to induce HIF-
stabilisation and
transactivation function (Huang et al.,
1996
; Ema et al.,
1999
; Carrero et al.,
2000
; Lando et al.,
2000
; Welsh et al.,
2002
). It is intriguing to speculate that PHD may thus also act as
an iron- and redox-sensor.
Reactive oxygen species
Apart from toxic accumulation during reoxygenation periods ROS have been
implicated as intracellular second messengers (reviewed in
Lander, 1997;
Nordberg and Arner, 2001
).
Various studies have demonstrated their influence on intracellular functions
in oxygen signaling, as shown in Fig.
6. Increased ROS in tissues act on different signal pathways, e.g.
the open probability of potassium channels
(Duprat et al., 1995
) or
via enhancement of GATA-2 binding activity to attenuate activity of
the Epo promoter (Tabata et al.,
2001
). Reports on HIF functions are particularly perplexing, since
different outcomes on HIF activity have been observed depending on whether ROS
are part of a normoxic, hypoxic or growth factor signaling cascade response,
and further complicated by contradictory reports as to whether ROS decrease or
increase with decreasing O2 concentrations (reviewed by
Fandrey and Genius, 2000
).
ROS visualization and measurement is technically challenging, which
explains why the majority of studies rely on either depleting the cells of ROS
by antioxidant treatment or increasing ROS by application of pro-oxidants.
These studies have documented an enhanced HIF- protein/HIF-reporter
gene expression upon ROS decrease under normoxic
(Salceda and Caro, 1997
;
Canbolat et al., 1998
;
Wartenberg et al., 2003
;
Görlach et al., 2003
;
Liu et al., 2004
) and an
attenuated HIF-
protein/HIF-reporter gene expression upon ROS increase
under hypoxic conditions (Wang et al.,
1995a
; Huang et al.,
1996
; Fandrey et al.,
1997
; Wiesener et al.,
1998
; Canbolat et al.,
1998
; Wartenberg et al.,
2003
; Görlach et al.,
2003
). One recent study provided further evidence for an ER-based
OH. production in regulating HIF degradation, mediated by
the Fenton reaction (Liu et al.,
2004
). These observations are in line with the concept that
declining O2 concentrations trigger the hypoxia response as a
result of decreased ROS intermediate production. The NAD(P)H oxidase as the
major donor of ROS would at the centre of this model convert
PO2 to a redox signal. How this signal is
transduced to HIF-
is not known. While ROS clearly affect the redox
state of the cell and thus thioredoxin and Ref-1 function (see above), it is
of interest to analyze whether ROS signaling in these settings interfaces with
PHD function. Interestingly, ROS have, for example, been shown to interfere
with mitochondrial function, affecting enzymes of the Krebs cycle at the level
of
-ketoglutarate dehydrogenase (KGDH) and SDH
(Nulton-Persson and Szweda,
2001
), which may influence 2-oxoglutarate levels (see above).
In contrast, during hypoxic events, mitochondria have been suggested to be
the major source of ROS formation at complex III
(Chandel et al., 1998) aiding
HIF-
stabilization (Chandel et al.,
2000
; Hirota and Semenza,
2001
). The issue of mitochondrial ROS formation is controversial,
however, as other groups have reported that the decreasing mitochondrial
membrane potential is associated with a reduction in mitochondrial ROS
formation (Lee et al., 2001
;
Jones et al., 2000
). Other
reports have shown a general ROS decrease in hypoxia
(Görlach et al., 2003
)
and further documented that a functioning mitochondrial respiratory chain may
not be necessary for HIF-
regulation
(Vaux et al., 2001
;
Srinivas et al., 2001
). In
addition, hypoxic signal transduction may require kinase/phosphatase activity
in certain cell types (Wang et al.,
1995b
; Zundel et al.,
2000
; Mottet et al.,
2003
; however, contrast
Alvarez-Tejado et al., 2002
).
Up to now, the putative corresponding phosphorylation targets such as
HIF-
, transcriptional coactivators or the presented mediators of the
oxygen-sensing pathway, have not been identified.
It is worth mentioning that not all ROS-mediated pathways on HIF activity
are part of an oxygen-signaling response, but rather expression of a delicate
integration of oxygen-sensing mechanisms into major signaling pathways.
Extracellular signals like growth factors and cytokines have been shown to
increase NAD(P)H oxidase-mediated ROS formation
(Görlach et al., 2000a),
with subsequent HIF stabilization under normoxic conditions
(Richard et al., 2000
;
Haddad and Land, 2001
).
However, this mode of activation seems to be cell-specific.
Other factors
The differences in target specificity and oxygen-dependent regulation of
the two orthologues HIF-1 and HIF-2
may add a further level of
complexity to oxygen signaling, though recent studies argue for a limited
HIF-2
function in hypoxia-induced signaling
(Park et al., 2003
;
Sowter et al., 2003
). One
report involving DNA microarray analysis identified distinct target genes
encoding for enzymes of the glycolytic pathway that were exclusively regulated
by HIF-1
, apart from several genes commonly regulated by HIF-1
and HIF-2
(Hu et al.,
2003
). In contrast, the study failed to distinguish genes uniquely
regulated by HIF-2
. However, specific target genes regulated
independently of HIF-1
do exist, as shown for VEGFR-2
(Elvert et al., 2003
) or
pneumocyte type II-dependent VEGF expression
(Compernolle et al., 2002
).
Indeed, studies analyzing the tissue-specific expression pattern of
HIF-1
(Stroka et al.,
2001
) and HIF-2
(Wiesener et al., 2003
)
suggest complementary rather than redundant functions of both proteins.
Interestingly, prolonged hypoxia may favor induction of HIF-2
due to
induction of natural antisense HIF-1
(aHIF), suggesting a qualitative
change in signaling response, depending on duration of the hypoxic stimulus
(Thrash-Bingham and Tartof,
1999
; Chun et al.,
2002
; Uchida et al.,
2004
).
Finally, a delicate degree of oxygen-sensing regulation was recently
suggested by a report showing that the PO2 may
differ in subcellular compartments under the control of signaling molecules
such as NO (Hagen et al.,
2003). Inhibition of mitochondrial respiration by NO under low
oxygen tension resulted in reduced mitochondrial oxygen consumption, leading
to an increase in intracellular oxygen availability and reactivation of prolyl
hydroxylation of HIF-
subunits. Thus, by changing the intracellular
PO2 distribution field, the metabolic oxidative
activity crucially influences the threshold of the cell to elicit adaptive
mechanisms in response to a given tissue PO2.
In this context, the different subcellular localizations of the putative
oxygen-sensing systems (cytochrome c, a592 in
mitochondria, NADPH-oxidase in cell membrane, PHD in cytoplasm and nucleus,
FIH in cytoplasm) should be taken into account. Thus, specific oxygen-sensing
cascades may, by means of their different oxygen sensitivities, cell-specific
and subcellular localization, help to tailor various adaptive and dynamic
responses according to differences in tissue oxygen availability.
![]() |
Conclusions |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
Acknowledgments |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Aberg, M. A., Aberg, N. D., Hedbacker, H., Oscarsson, J. and
Eriksson, P. S. (2000). Peripheral infusion of IGF-I
selectively induces neurogenesis in the adult rat hippocampus. J.
Neurosci. 20,2896
-2903.
Aboul-Enein, F., Rauschka, H., Kornek, B., Stadelmann, C., Stefferl, A., Bruck, W., Lucchinetti, C., Schmidbauer, M., Jellinger, K. and Lassmann, H. (2003). Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J. Neuropathol. Exp. Neurol. 62,25 -33.[Medline]
Acker, H., Lubbers, D. W., Purves, M. J. and Tan, E. D. (1980). Measurements of the partial pressure of oxygen in the carotid body of fetal sheep and newborn lambs. J. Dev. Physiol. 2,323 -328.[Medline]
Acker, T. and Plate, K. H. (2002). A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology. J. Mol. Med. 80,562 -575.[CrossRef][Medline]
Acker, T. and Plate, K. H. (2003). Role of hypoxia in tumor angiogenesis molecular and cellular angiogenic crosstalk. Cell Tissue Res. 80,562 -575.
Althausen, S., Mengesdorf, T., Mies, G., Olah, L., Nairn, A. C., Proud, C. G. and Paschen, W. (2001). Changes in the phosphorylation of initiation factor eIF-2alpha, elongation factor eEF-2 and p70 S6 kinase after transient focal cerebral ischaemia in mice. J. Neurochem. 78,779 -787.[CrossRef][Medline]
Alvarez-Tejado, M., Alfranca, A., Aragones, J., Vara, A.,
Landazuri, M. O. and del Peso, L. (2002). Lack of evidence
for the involvement of the phosphoinositide 3-kinase/Akt pathway in the
activation of hypoxia-inducible factors by low oxygen tension. J.
Biol. Chem. 277,13508
-13517.
Archer, S. L., Reeve, H. L., Michelakis, E., Puttagunta, L.,
Waite, R., Nelson, D. P., Dinauer, M. C. and Weir, E. K.
(1999). O-2 sensing is preserved in mice lacking the gp91 phox
subunit of NADPH oxidase. Proc. Natl. Acad. Sci. USA
96,7944
-7949.
Arsham, A. M., Howell, J. J. and Simon, M. C.
(2003). A novel hypoxia-inducible factor-independent hypoxic
response regulating mammalian target of rapamycin and its targets.
J. Biol. Chem. 278,29655
-29660.
Arthur, P. G., Ngo, C. T., Moretta, P. and Guppy, M.
(1999). Lack of oxygen sensing by mitochondria in platelets.
Eur. J. Biochem. 266,215
-219.
Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z. and Lindvall, O. (2002). Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 8, 963-970.[CrossRef][Medline]
Astuti, D., Latif, F., Dallol, A., Dahia, P. L., Douglas, F., George, E., Skoldberg, F., Husebye, E. S., Eng, C. and Maher, E. R. (2001). Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet. 69, 49-54.[CrossRef][Medline]
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence,
E. C., Myssiorek, D., Bosch, A., van der May, A., Taschner, P. E., Rubinstein,
W. S., Myers, E. N. et al. (2000). Mutations in SDHD, a
mitochondrial complex II gene, in hereditary paraganglioma.
Science 287,848
-851.
Beck, H., Acker, T., Wiessner, C., Allegrini, P. R. and Plate,
K. H. (2000). Expression of angiopoietin-1, angiopoietin-2,
and tie receptors after middle cerebral artery occlusion in the rat.
Am. J. Pathol. 157,1473
-1483.
Bence, N. F., Sampat, R. M. and Kopito, R. R.
(2001). Impairment of the ubiquitin-proteasome system by protein
aggregation. Science
292,1552
-1555.
Bergeron, M., Gidday, J. M., Yu, A. Y., Semenza, G. L., Ferriero, D. M. and Sharp, F. R. (2000). Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann. Neurol. 48,285 -296.[CrossRef][Medline]
Bergeron, M., Yu, A. Y., Solway, K. E., Semenza, G. L. and Sharp, F. R. (1999). Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur. J. Neurosci. 11,4159 -4170.[CrossRef][Medline]
Bernaudin, M., Marti, H. H., Roussel, S., Divoux, D., Nouvelot, A., MacKenzie, E. T. and Petit, E. (1999). A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19,643 -651.[Medline]
Bernaudin, M., Nedelec, A. S., Divoux, D., MacKenzie, E. T., Petit, E. and Schumann-Bard, P. (2002). Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab. 22,393 -403.[CrossRef][Medline]
Berra, E., Benizri, E., Ginouves, A., Volmat, V., Roux, D. and
Pouyssegur, J. (2003). HIF prolyl-hydroxylase 2 is the key
oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.
EMBO J. 22,4082
-4090.
Bickler, P. E., Fahlram, C. S. and Taylor, D. M. (2003). Oxygen sensitivity of NMIDA receptors: Relationship to NR2 subunit composition and hypoxia tolerance of neonatal neurons. Neuroscience 118,25 -35.[CrossRef][Medline]
Bilton, R. L. and Booker, G. W. (2003). The
subtle side to hypoxia inducible factor (HIFalpha) regulation. Eur.
J. Biochem. 270,791
-798.
Bishop, G. M., Robinson, S. R., Liu, Q., Perry, G., Atwood, C. S. and Smith, M. A. (2002). Iron: a pathological mediator of Alzheimer disease? Dev. Neurosci. 24,184 -187.[CrossRef][Medline]
Blancher, C., Moore, J. W., Talks, K. L., Houlbrook, S. and
Harris, A. L. (2000). Relationship of hypoxia-inducible
factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth
factor induction and hypoxia survival in human breast cancer cell lines.
Cancer Res. 60,7106
-7113.
Blouw, B., Song, H., Tihan, T., Bosze, J., Ferrara, N., Gerber, H. P., Johnson, R. S. and Bergers, G. (2003). The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 4,133 -146.[CrossRef][Medline]
Brickley, S. G., Revilla, V., Cull-Candy, S. G., Wisden, W. and Farrant, M. (2001). Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature 409,88 -92.[CrossRef][Medline]
Bruick, R. K. and McKnight, S. L. (2001). A
conserved family of prolyl-4-hydroxylases that modify HIF.
Science 294,1337
-1340.
Canbolat, O., Fandrey, J. and Jelkmann, W. (1998). Effects of modulators of the production and degradation of hydrogen-peroxide on erythropoietin synthesis. Resp. Physiol. 114,175 -183.[CrossRef][Medline]
Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P. et al. (1998). Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394,485 -490.[CrossRef][Medline]
Carmeliet, P. and Storkebaum, E. (2002). Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders. Semin. Cell Dev. Biol. 13, 39-53.[CrossRef][Medline]
Carrero, P., Okamoto, K., Coumailleau, P., O'Brien, S., Tanaka,
H. and Poellinger, L. (2000). Redox-regulated recruitment of
the transcriptional coactivators CREB-binding protein and SRC-1 to
hypoxia-inducible factor 1alpha. Mol. Cell Biol.
20,402
-415.
Chan, D. A., Sutphin, P. D., Denko, N. C. and Giaccia, A. J.
(2002). Role of prolyl hydroxylation in oncogenically stabilized
hypoxia-inducible factor-1alpha. J. Biol. Chem.
277,40112
-40117.
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu C. E.,
Simon, M. C. and Schumacker, P. T. (1998). Mitochondrial
reactive oxygen species trigger hypoxia-induced transcription.
Proc. Natl. Acad. Sci. USA
95,11715
-11720.
Chandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T.
M., Melendez, J. A., Rodriguez, A. M. and Schumacker, P. T.
(2000). Reactive oxygen species generated at mitochondrial
complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a
mechanism of O2 sensing. J. Biol. Chem.
275,25130
-25138.
Chavez, J. C., Agani, F., Pichiule, P. and LaManna, J. C.
(2000). Expression of hypoxia-inducible factor-1alpha in the
brain of rats during chronic hypoxia. J. Appl.
Physiol. 89,1937
-1942.
Chavez, J. C. and LaManna, J. C. (2003). Hypoxia-inducible factor-1alpha accumulation in the rat brain in response to hypoxia and ischemia is attenuated during aging. Adv. Exp. Med. Biol. 510,337 -341.[Medline]
Chun, Y. S., Choi, E., Kim, T. Y., Kim, M. S. and Park, J. W. (2002). A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible factor-1alpha gene. Biochem. J. 362,71 -79.[CrossRef][Medline]
Cioffi, C. L., Liu, X. Q., Kosinski, P. A., Garay, M. and Bowen, B. R. (2003). Differential regulation of HIF-1 alpha prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells. Biochem. Biophys. Res. Commun. 303,947 -953.[CrossRef][Medline]
Cluskey, S. and Ramsden, D. B. (2001).
Mechanisms of neurodegeneration in amyotrophic lateral sclerosis.
Mol. Pathol. 54,386
-392.
Compernolle, V., Brusselmans, K., Acker, T., Hoet, P., Tjwa, M., Beck, H., Plaisance, S., Dor, Y., Keshet, E., Lupu, F. et al. (2002). Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat. Med. 8, 702-710.[Medline]
Cross, A. R., Henderson, L., Jones, O. T., Delpiano, M. A., Hentschel, J. and Acker, H. (1990). Involvement of an NAD(P)H oxidase as a PO2 sensor protein in the rat carotid body. Biochem. J. 272,743 -747.[Medline]
D'Angelo, G., Duplan, E., Boyer, N., Vigne, P. and Frelin,
C. (2003). Hypoxia up-regulates prolyl hydroxylase activity:
a feedback mechanism that limits HIF-1 responses during reoxygenation.
J. Biol. Chem. 278,38183
-38187.
del Peso, L., Castellanos, M. C., Temes, E., Martin-Puig, S.,
Cuevas, Y., Olmos, G. and Landazuri, M. O. (2003). The von
Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the
transcription of the HIF-proline hydroxylase genes in response to low oxygen.
J. Biol. Chem. 278,48690
-48695.
Denko, N., Wernke-Dollries, K., Johnson, A. B., Hammond, E.,
Chiang, C. M. and Barton, M. C. (2003a). Hypoxia actively
represses transcription by inducing negative cofactor 2 (Dr1/DrAP1) and
blocking preinitiation complex assembly. J. Biol.
Chem. 278,5744
-5749.
Denko, N. C., Fontana, L. A., Hudson, K. M., Sutphin, P. D., Raychaudhuri, S., Altman, R. and Giaccia, A. J. (2003b). Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22,5907 -5914.[CrossRef][Medline]
Digicaylioglu, M. and Lipton, S. A. (2001). Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412,641 -647.[CrossRef][Medline]
Dirnagl, U., Simon, R. P. and Hallenbeck, J. M. (2003). Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 26,248 -254.[CrossRef][Medline]
Doetsch, F. (2003). The glial identity of neural stem cells. Nat. Neurosci. 6,1127 -1134.[CrossRef][Medline]
Duprat, F., Guillemare, E., Romey, G., Fink, M., Lesage, F., Lazdunski, M. and Honore, E. (1995). Susceptibility of cloned K+ channels to reactive oxygen species. Proc. Natl. Acad. Sci. USA 92,11796 -11800.[Abstract]
Elvert, G., Kappel, A., Heidenreich, R., Englmeier, U., Lanz,
S., Acker, T., Rauter, M., Plate, K., Sieweke, M., Breier, G. and Flamme,
I. (2003). Cooperative interaction of hypoxia-inducible
factor-2alpha (HIF-2alpha) and Ets-1 in the transcriptional activation of
vascular endothelial growth factor receptor-2 (Flk-1). J. Biol.
Chem. 278,7520
-7530.
Ema, M., Hirota, K., Mimura, J., Abe, H., Yodoi, J., Sogawa, K.,
Poellinger, L. and Fujii-Kuriyama, Y. (1999). Molecular
mechanisms of transcription activation by HLF and HIF1alpha in response to
hypoxia: their stabilization and redox signal-induced interaction with
CBP/p300. EMBO J. 18,1905
-1914.
Eng, C., Kiuru, M., Fernandez, M. J. and Aaltonen, L. A. (2003). A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat. Rev. Cancer 3, 193-202.[CrossRef][Medline]
Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A. et al. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107,43 -54.[Medline]
Erez, N., Milyavsky, M., Eilam, R., Shats, I., Goldfinger, N.
and Rotter, V. (2003). Expression of prolyl-hydroxylase-1
(PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and
inhibits tumor growth. Cancer Res.
63,8777
-8783.
Fandrey, J., Frede, S., Ehleben, W., Porwol, T., Acker, H. and Jelkmann, W. (1997). Cobalt chloride and desferrioxamine antagonize the inhibition of erythropoietin production by reactive oxygen species. Kidney Int. 51,492 -496.[Medline]
Fandrey, J. and Genius, J. (2000). Reactive oxygen species as regulators of oxygen dependent gene expression. Adv. Exp. Med. Biol. 475,153 -159.[Medline]
Fu, X. W., Wang, D., Nurse, C. A., Dinauer, M. C. and Cutz,
E. (2000). NADPH oxidase is an O2 sensor in airway
chemoreceptors: evidence from K+ current modulation in wild-type
and oxidase-deficient mice. Proc. Natl. Acad. Sci. USA
97,4374
-4379.
Görlach, A., Camenisch, G., Kvietikova, I., Vogt, L., Wenger, R. H. and Gassmann, M. (2000). Efficient translation of mouse hypoxia-inducible factor-1alpha under normoxic and hypoxic conditions. Biochim. Biophys. Acta 1493,125 -134.[Medline]
Görlach, A., Berchner-Pfannschmidt U., Wotzlaw C., Cool R. H., Fandrey, J., Acker, H., Jungermann K. and Kietzmann T. (2003). Reactive oxygen species modulate HIF-1 mediated PAI-1 expression: Involvement of the GTPase Rac1. Thromb. Haem. 89,926 -935.[Medline]
Görlach, A., Brandes, R. P., Bassus, S., Kronemann, N.,
Kirchmaier, C. M., Busse, R. and Schini-Kerth, V. B. (2000a).
Oxidative stress and expression of p22phox are involved in the up-regulation
of tissue factor in vascular smooth muscle cells in response to activated
platelets. FASEB J. 14,1518
-1528.
Görlach, A., Brandes, R. P., Nguyen, K., Amidi, M.,
Dehghani, F. and Busse, R. (2000b). A gp91phox containing
NADPH oxidase selectively expressed in endothelial cells is a major source of
oxygen radical generation in the arterial wall [see comments].
Circ. Res. 87,26
-32.
Gradin, K., McGuire, J., Wenger, R. H., Kvietikova, I., Whitelaw, M. L., Toftgard, R., Tora, L., Gassmann, M. and Poellinger, L. (1996). Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell Biol. 16,5221 -5231.[Abstract]
Haddad, J. J. and Land, S. C. (2001). A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha. FEBS Lett. 505,269 -274.[CrossRef][Medline]
Hagen, T., Taylor, C. T., Lam, F. and Moncada, S.
(2003). Redistribution of intracellular oxygen in hypoxia by
nitric oxide: effect on HIF1alpha. Science
302,1975
-1978.
Halterman, M. W., Miller, C. C. and Federoff, H. J.
(1999). Hypoxia-inducible factor-1alpha mediates hypoxia-induced
delayed neuronal death that involves p53. J. Neurosci.
19,6818
-6824.
Hata, R., Maeda, K., Hermann, D., Mies, G. and Hossmann, K. A. (2000). Dynamics of regional brain metabolism and gene expression after middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 20,306 -315.[CrossRef][Medline]
Hewitson, K. S., McNeill, L. A., Riordan, M. V., Tian, Y. M.,
Bullock, A. N., Welford, R. W., Elkins, J. M., Oldham, N. J., Bhattacharya,
S., Gleadle, J. M. et al. (2002). Hypoxia inducible factor
(HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and
is related to the cupin structural family. J. Biol.
Chem. 277,26351
-26355.
Hirota, K. and Semenza, G. L. (2001). Rac1
activity is required for the activation of hypoxia-inducible factor 1.
J. Biol. Chem. 276,21166
-21172.
Hirsilä, M., Koivunen, P., Gunzler, V., Kivirikko, K. I.
and Myllyharju, J. (2003). Characterization of the human
prolyl 4-hydroxylases that modify the hypoxia-inducible factor HIF.
J. Biol. Chem. 278,30772
-30780.
Hochachka, P. W. and Lutz, P. L. (2001). Mechanism, origin, and evolution of anoxia tolerance in animals. Comp. Biochem. Physiol. 130B,435 -459.
Hu, C. J., Wang, L. Y., Chodosh, L. A., Keith, B. and Simon, M.
C. (2003). Differential roles of hypoxia-inducible factor
1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol.
Cell Biol. 23,9361
-9374.
Huang, L. E., Arany, Z., Livingston, D. M. and Bunn, H. F.
(1996). Activation of hypoxia-inducible transcription factor
depends primarily upon redox-sensitive stabilization of its alpha subunit.
J. Biol. Chem. 271,32253
-32259.
Huang, L. E. and Bunn, H. F. (2003).
Hypoxia-inducible factor and its biomedical relevance. J. Biol.
Chem. 278,19575
-19578.
Isaacs, J. S., Jung, Y. J., Mimnaugh, E. G., Martinez, A.,
Cuttitta, F. and Neckers, L. M. (2002). Hsp90 regulates a von
Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative
pathway. J. Biol. Chem.
277,29936
-29944.
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner,
E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y. and
Semenza, G. L. (1998). Cellular and developmental control of
O2 homeostasis by hypoxia-inducible factor 1 alpha.
Genes Dev. 12,149
-162.
Jeong, J. W., Bae, M. K., Ahn, M. Y., Kim, S. H., Sohn, T. K., Bae, M. H., Yoo, M. A., Song, E. J., Lee, K. J. and Kim, K. W. (2002). Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 111,709 -720.[Medline]
Jiang, C. and Haddad, G. G. (1994). A direct mechanism for sensing low oxygen levels by central neurons. Proc. Natl. Acad. Sci. USA 91,7198 -7201.[Abstract]
Jin, K., Mao, X. O., Sun, Y., Xie, L. and Greenberg, D. A.
(2002a). Stem cell factor stimulates neurogenesis in vitro and in
vivo. J. Clin. Invest.
110,311
-319.
Jin, K., Minami, M., Lan, J. Q., Mao, X. O., Batteur, S., Simon,
R. P. and Greenberg, D. A. (2001). Neurogenesis in dentate
subgranular zone and rostral subventricular zone after focal cerebral ischemia
in the rat. Proc. Natl. Acad. Sci. USA
98,4710
-4715.
Jin, K., Zhu, Y., Sun, Y., Mao, X. O., Xie, L. and Greenberg, D.
A. (2002b). Vascular endothelial growth factor (VEGF)
stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad.
Sci. USA 99,11946
-11950.
Jogi, A., Ora, I., Nilsson, H., Lindeheim, A., Makino, Y.,
Poellinger, L., Axelson, H. and Pahlman, S. (2002). Hypoxia
alters gene expression in human neuroblastoma cells toward an immature and
neural crest-like phenotype. Proc. Natl. Acad. Sci.
USA 99,7021
-7026.
Jones, R. D., Hancock, J. T. and Morice, A. H. (2000). NADPH oxidase: a universal oxygen sensor? [Review]. Free Radic. Biol. Med. 29,416 -424.[CrossRef][Medline]
Kannurpatti, S. S., Biswal, B. B. and Hudetz, A. G. (2003). Regional dynamics of the fMRI-BOLD signal response to hypoxia-hypercapnia in the rat brain. J. Magnet. Res. Imag. 17,641 -647.[CrossRef][Medline]
Kazemian, P., Stephenson, R., Yeger, H. and Cutz, E. (2001). Respiratory control in neonatal mice with NADPH oxidase deficiency. Resp. Physiol. 126,89 -101.[CrossRef][Medline]
Kietzmann, T., Knabe, W. and Schmidt-Kastner, R. (2001). Hypoxia and hypoxia-inducible factor modulated gene expression in brain: involvement in neuroprotection and cell death. Eur. Arch. Psych. Clin. Neurosci. 251,170 -178.[CrossRef][Medline]
Kim, M. S., Kwon, H. J., Lee, Y. M., Baek, J. H., Jang, J. E., Lee, S. W., Moon, E. J., Kim, H. S., Lee, S. K., Chung, H. Y. et al. (2001). Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 7, 437-443.[CrossRef][Medline]
Knowles, H. J., Raval, R. R., Harris, A. L. and Ratcliffe, P.
J. (2003). Effect of ascorbate on the activity of
hypoxia-inducible factor in cancer cells. Cancer Res.
63,1764
-1768.
Koong, A. C., Chen, E. Y., Mivechi, N. F., Denko, N. C., Stambrook, P. and Giaccia, A. J. (1994). Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res. 54,5273 -5279.[Abstract]
Koumenis, C., Naczki, C., Koritzinsky, M., Rastani, S., Diehl,
A., Sonenberg, N., Koromilas, A. and Wouters, B. G. (2002).
Regulation of protein synthesis by hypoxia via activation of the endoplasmic
reticulum kinase PERK and phosphorylation of the translation initiation factor
eIF2alpha. Mol. Cell Biol.
22,7405
-7416.
Krishnamachary, B., Berg-Dixon, S., Kelly, B., Agani, F.,
Feldser, D., Ferreira, G., Iyer, N., LaRusch, J., Pak, B., Taghavi, P. and
Semenza, G. L. (2003). Regulation of colon carcinoma cell
invasion by hypoxia-inducible factor 1. Cancer Res.
63,1138
-1143.
Kung, A. L., Wang, S., Klco, J. M., Kaelin, W. G. and Livingston, D. M. (2000). Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat. Med. 6,1335 -1340.[CrossRef][Medline]
Lambeth, J. D., Cheng, G., Arnold, R. S. and Edens, W. A. (2000). Novel homologs of gp91phox. Trends Biochem. Sci. 25,459 -461.[CrossRef][Medline]
Lambrechts, D., Storkebaum, E., Morimoto, M., Del Favero, J., Desmet, F., Marklund, S. L., Wyns, S., Thijs, V., Andersson, J., van Marion, I., Al Chalabi, A. et al. (2003). VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 34,383 -394.[CrossRef][Medline]
Lamszus, K., Laterra, J., Westphal, M. and Rosen, E. M. (1999). Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int. J. Dev. Neurosci. 17,517 -530.[CrossRef][Medline]
Lander, H. M. (1997). An essential role for
free-radicals and derived species in signal-transduction. FASEB
J. 11,118
-124.
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J. and
Whitelaw, M. L. (2002). Asparagine hydroxylation of the HIF
transactivation domain a hypoxic switch. Science
295,858
-861.
Lando, D., Pongratz, I., Poellinger, L. and Whitelaw, M. L.
(2000). A redox mechanism controls differential DNA binding
activities of hypoxia-inducible factor (HIF) 1alpha and the HIF-like factor.
J. Biol. Chem. 275,4618
-4627.
Lang, K. J., Kappel, A. and Goodall, G. J.
(2002). Hypoxia-inducible factor-1alpha mRNA contains an internal
ribosome entry site that allows efficient translation during normoxia and
hypoxia. Mol. Biol. Cell
13,1792
-1801.
Lee, I., Bender, E., Arnold, S. and Kadenbach, B. (2001). New control of mitochondrial membrane potential and ROS formation a hypothesis. Biol. Chem. 382,1629 -1636.[Medline]
Leniger-Follert, E., Lubbers, D. W. and Wrabetz, W. (1975). Regulation of local tissue PO2 of the brain cortex at different arterial O2 pressures. Pflugers Arch. 359, 81-95.[Medline]
Lieb, M. E., Menzies, K., Moschella, M. C., Ni, R. and Taubman, M. B. (2002). Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem. Cell Biol. 80,421 -426.[Medline]
Linke, S., Stojkoski, C., Kewley, R. J., Booker, G. W.,
Whitelaw, M. L. and Peet, D. J. (2004). Substrate
requirements of the oxygen-sensing asparaginyl hydroxylase Factor Inhibiting
HIF. J. Biol. Chem. 279,14871
-14878.
Liu, J., Solway, K., Messing, R. O. and Sharp, F. R.
(1998). Increased neurogenesis in the dentate gyrus after
transient global ischemia in gerbils. J. Neurosci.
18,7768
-7778.
Liu, Q., Berchner-Pfannschmidt, U., Möller, U., Brecht, M.,
Wotzlaw, C., Acker, H. and Jungermann, K. (2004). A Fenton
reaction at the endoplasmic reticulum is involved in the redox control of
hypoxia-inducible gene expression. Proc. Natl. Acad. Sci.
USA 101,4302
-4307.
Lok, C. N. and Ponka, P. (1999). Identification
of a hypoxia response element in the transferrin receptor gene. J.
Biol. Chem. 274,24147
-24152.
Mabjeesh, N. J., Post, D. E., Willard, M. T., Kaur, B., Van
Meir, E. G., Simons, J. W. and Zhong, H. (2002). Geldanamycin
induces degradation of hypoxia-inducible factor 1alpha protein via the
proteosome pathway in prostate cancer cells. Cancer
Res. 62,2478
-2482.
Maingret, F., Patel, A. J., Lazdunski, M. and Honore, E.
(2001). The endocannabinoid anandamide is a direct and selective
blocker of the background K(+) channel TASK-1. EMBO
J. 20,47
-54.
Makino, Y., Kanopka, A., Wilson, W. J., Tanaka, H. and
Poellinger, L. (2002). Inhibitory PAS domain protein (IPAS)
is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha
locus. J. Biol. Chem.
277,32405
-32408.
Marti, H. J., Bernaudin, M., Bellail, A., Schoch, H., Euler, M.,
Petit, E. and Risau, W. (2000). Hypoxia-induced vascular
endothelial growth factor expression precedes neovascularization after
cerebral ischemia. Am. J. Pathol.
156,965
-976.
Martin de la Vega, Burda, J., Nemethova, M., Quevedo, C., Alcazar, A., Martin, M. E., Danielisova, V., Fando, J. L. and Salinas, M. (2001). Possible mechanisms involved in the down-regulation of translation during transient global ischaemia in the rat brain. Biochem. J. 357,819 -826.[CrossRef][Medline]
Martin, M. E., Munoz, F. M., Salinas, M. and Fando, J. L. (2000). Ischaemia induces changes in the association of the binding protein 4E-BP1 and eukaryotic initiation factor (eIF) 4G to eIF4E in differentiated PC12 cells. Biochem. J. 351,327 -334.[CrossRef][Medline]
Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G.,
Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W. and Ratcliffe, P.
J. (1997). Hypoxia-inducible factor-1 modulates gene
expression in solid tumors and influences both angiogenesis and tumor growth.
Proc. Natl. Acad. Sci. USA
94,8104
-8109.
Metzen, E., Berchner-Pfannschmidt, U., Stengel, P., Marxsen, J.
H., Stolze, I., Klinger, M., Huang, W. Q., Wotzlaw, C., Hellwig-Burgel, T.,
Jelkmann, W. et al. (2003). Intracellular localisation of
human HIF-1 alpha hydroxylases: implications for oxygen sensing. J.
Cell Sci. 116,1319
-1326.
Mills, E. and Jöbsis, F. F. (1972).
Mitochondrial respiratory chain of carotid body and chemoreceptor response to
changes in oxygen tension. J. Neurophysiol.
35,405
-428.
Minet, E., Mottet, D., Michel, G., Roland, I., Raes, M., Remacle, J. and Michiels, C. (1999). Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction. FEBS Lett. 460,251 -256.[CrossRef][Medline]
Morrison, S. J., Csete, M., Groves, A. K., Melega, W., Wold, B.
and Anderson, D. J. (2000). Culture in reduced levels of
oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural
crest stem cells. J. Neurosci.
20,7370
-7376.
Mottet, D., Dumont, V., Deccache, Y., Demazy, C., Ninane, N.,
Raes, M. and Michiels, C. (2003). Regulation of
hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the
phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in
HepG2 cells. J. Biol. Chem.
278,31277
-31285.
Mukhopadhyay, C. K., Mazumder, B. and Fox, P. L.
(2000). Role of hypoxia-inducible factor-1 in transcriptional
activation of ceruloplasmin by iron deficiency. J. Biol.
Chem. 275,21048
-21054.
Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verastegui, E. and Zlotnik, A. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410,50 -56.[CrossRef][Medline]
Nakatomi, H., Kuriu, T., Okabe, S., Yamamoto, S., Hatano, O., Kawahara, N., Tamura, A., Kirino, T. and Nakafuku, M. (2002). Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110,429 -441.[Medline]
Niemann, S. and Muller, U. (2000). Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat. Genet. 26,268 -270.[CrossRef][Medline]
Noble, M., Smith, J., Power, J. and Mayer-Proschel, M.
(2003). Redox state as a central modulator of precursor cell
function. Ann. NY Acad. Sci.
991,251
-271.
Nordberg, J. and Arner, E. S. (2001). Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31,1287 -1312.[CrossRef][Medline]
Nulton-Persson, A. C. and Szweda, L. I. (2001).
Modulation of mitochondrial function by hydrogen peroxide. J. Biol.
Chem. 276,23357
-23361.
O'Kelly, I., Peers, C. and Kemp, P. J. (2001). NADPH oxidase does not account fully for O2-sensing in model airway chemoreceptor cells. Biochem. Biophys. Res. Commun. 283,1131 -1134.[CrossRef][Medline]
O'Kelly I., Lewis A., Peers, C. and Kemp P. J.
(2000). O2 sensing by airway chemoreceptor-derived
cells. J. Biol. Chem.
275,7684
-7692.
Oehme, F., Ellinghaus, P., Kolkhof, P., Smith, T. J., Ramakrishnan, S., Hutter, J., Schramm, M. and Flamme, I. (2002). Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem. Biophys. Res. Commun. 296,343 -349.[CrossRef][Medline]
Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Van Dorpe, J., Hellings, P., Gorselink, M., Heymans, S. et al. (2001). Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28,131 -138.[CrossRef][Medline]
Park, S. K., Dadak, A. M., Haase, V. H., Fontana, L., Giaccia,
A. J. and Johnson, R. S. (2003). Hypoxia-induced gene
expression occurs solely through the action of hypoxia-inducible factor 1alpha
(HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha. Mol. Cell
Biol. 23,4959
-4971.
Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S. and Comoglio, P. M. (2003). Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3,347 -361.[Medline]
Piret, J. P., Mottet, D., Raes, M. and Michiels, C. (2002). Is HIF-1alpha a pro- or an anti-apoptotic protein? Biochem. Pharmacol. 64,889 -892.[CrossRef][Medline]
Porwol, T., Ehleben, W., Brand, V. and Acker, H. (2001). Tissue oxygen sensor function of NADPH oxidase isoforms, an unusual cytochrome aa3 and reactive oxygen species. Respir. Physiol 128,331 -348.[CrossRef][Medline]
Prass, K., Ruscher, K., Karsch, M., Isaev, N., Megow, D., Priller, J., Scharff, A., Dirnagl, U. and Meisel, A. (2002). Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J. Cereb. Blood Flow Metab. 22,520 -525.[Medline]
Prass, K., Scharff, A., Ruscher, K., Lowl, D., Muselmann, C.,
Victorov, I., Kapinya, K., Dirnagl, U. and Meisel, A. (2003).
Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin.
Stroke 34,1981
-1986.
Rakhit, R., Cunningham, P., Furtos-Matei, A., Dahan, S., Qi, X.
F., Crow, J. P., Cashman, N. R., Kondejewski, L. H. and Chakrabartty, A.
(2002). Oxidation-induced misfolding and aggregation of
superoxide dismutase and its implications for amyotrophic lateral sclerosis.
J. Biol. Chem. 277,47551
-47556.
Richard, D. E., Berra, E. and Pouyssegur, J.
(2000). Nonhypoxic pathway mediates the induction of
hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J.
Biol. Chem. 275,26765
-26771.
Rolfs, A., Kvietikova, I., Gassmann, M. and Wenger, R. H.
(1997). Oxygen-regulated transferrin expression is mediated by
hypoxia-inducible factor-1. J. Biol. Chem.
272,20055
-20062.
Roy, A., Rozanov, C., Mokashi, A., Daudu, P., Al mehdi, A. B., Shams, H. and Lahiri, S. (2000). Mice lacking in gp91 phox subunit of NAD(P)H oxidase showed glomus cell [Ca2+](i) and respiratory responses to hypoxia. Brain Res. 872,188 -193.[CrossRef][Medline]
Ryan, H. E., Lo, J. and Johnson, R. S. (1998).
HIF-1 alpha is required for solid tumor formation and embryonic
vascularization. EMBO J.
17,3005
-3015.
Salceda, S. and Caro, J. (1997).
Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by
the ubiquitin-proteasome system under normoxic conditions. Its stabilization
by hypoxia depends on redox-induced changes. J. Biol.
Chem. 272,22642
-22647.
Sanders, K. A., Sundar, K. M., He, L., Dinger, B., Fidone, S.
and Hoidal, J. R. (2002). Role of components of the
phagocytic NADPH oxidase in oxygen sensing. J. Appl.
Physiol. 93,1357
-1364.
Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni,
A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L.,
Mantovani, A., Melillo, G. and Sica, A. (2003). Regulation of
the chemokine receptor CXCR4 by hypoxia. J. Exp. Med.
198,1391
-1402.
Schipani, E., Ryan, H. E., Didrickson, S., Kobayashi, T.,
Knight, M. and Johnson, R. S. (2001). Hypoxia in cartilage:
HIF-1alpha is essential for chondrocyte growth arrest and survival.
Genes Dev. 15,2865
-2876.
Seagroves, T. N., Hadsell, D., McManaman, J., Palmer, C., Liao,
D., McNulty, W., Welm, B., Wagner, K. U., Neville, M. and Johnson, R. S.
(2003). HIF1alpha is a critical regulator of secretory
differentiation and activation, but not vascular expansion, in the mouse
mammary gland. Development
130,1713
-1724.
Semenza, G. L. (2003). Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732.[CrossRef][Medline]
Shingo, T., Sorokan, S. T., Shimazaki, T. and Weiss, S.
(2001). Erythropoietin regulates the in vitro and in vivo
production of neuronal progenitors by mammalian forebrain neural stem cells.
J. Neurosci. 21,9733
-9743.
Soucek, T., Cumming, R., Dargusch, R., Maher, P. and Schubert, D. (2003). The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39,43 -56.[CrossRef][Medline]
Sowter, H. M., Raval, R., Moore, J., Ratcliffe, P. J. and
Harris, A. L. (2003). Predominant role of hypoxia-inducible
transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the
transcriptional response to hypoxia. Cancer Res.
63,6130
-6134.
Srinivas, V., Leshchinsky, I., Sang, N., King, M. P., Minchenko,
A. and Caro, J. (2001). Oxygen sensing and HIF-1 activation
does not require an active mitochondrial respiratory chain electron-transfer
pathway. J. Biol. Chem.
276,21995
-21998.
Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J. and Krek, W. (2003). Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425,307 -311.[CrossRef][Medline]
Storkebaum, E. and Carmeliet, P. (2004). VEGF:
a critical player in neurodegeneration. J. Clin.
Invest 113,14
-18.
Streller, T., Huckstorf, C., Pfeiffer, C. and Acker, H.
(2002). Unusual cytochrome a(592) with low
PO2 affinity correlates as putative oxygen
sensor with rat carotid body chemoreceptor discharge. FASEB
J. 16,1277
-1279.
Stroka, D. M., Burkhardt, T., Desbaillets, I., Wenger, R. H.,
Neil, D. A., Bauer, C., Gassmann, M. and Candinas, D. (2001).
HIF-1 is expressed in normoxic tissue and displays an organ-specific
regulation under systemic hypoxia. FASEB J.
15,2445
-2453.
Studer, L., Csete, M., Lee, S. H., Kabbani, N., Walikonis, J.,
Wold, B. and McKay, R. (2000). Enhanced proliferation,
survival, and dopaminergic differentiation of CNS precursors in lowered
oxygen. J. Neurosci. 20,7377
-7383.
Sullivan, J. M., Alousi, S. S., Hikade, K. R., Bahu, N. J., Rafols, J. A., Krause, G. S. and White, B. C. (1999). Insulin induces dephosphorylation of eukaryotic initiation factor 2alpha and restores protein synthesis in vulnerable hippocampal neurons after transient brain ischemia. J. Cereb. Blood Flow Metab. 19,1010 -1019.[CrossRef][Medline]
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A.
and Greenberg, D. A. (2003). VEGF-induced neuroprotection,
neurogenesis, and angiogenesis after focal cerebral ischemia. J.
Clin. Invest. 111,1843
-1851.
Tabata, M., Tarumoto, T., Ohmine, K., Furukawa, Y., Hatake, K., Ozawa, K., Hasegawa, Y., Mukai, H., Yamamoto, M. and Imagawa, S. (2001). Stimulation of GATA-2 as a mechanism of hydrogen peroxide suppression in hypoxia-induced erythropoietin gene expression. J. Cell. Physiol. 186,260 -267.[CrossRef][Medline]
Tacchini, L., Bianchi, L., Bernelli-Zazzera, A. and Cairo,
G. (1999). Transferrin receptor induction by hypoxia.
HIF-1-mediated transcriptional activation and cell-specific
post-transcriptional regulation. J. Biol. Chem.
274,24142
-24146.
Takagi, Y., Nozaki, K., Takahashi, J., Yodoi, J., Ishikawa, M. and Hashimoto, N. (1999). Proliferation of neuronal precursor cells in the dentate gyrus is accelerated after transient forebrain ischemia in mice. Brain Res. 831,283 -287.[CrossRef][Medline]
Taylor, J. P., Hardy, J. and Fischbeck, K. H.
(2002). Toxic proteins in neurodegenerative disease.
Science 296,1991
-1995.
Thompson, J. K., Peterson, M. R. and Freeman, R. D.
(2003). Single-neuron activity and tissue oxygenation in the
cerebral cortex. Science
299,1070
-1072.
Thrash-Bingham, C. A. and Tartof, K. D. (1999). aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia. J. Natl. Cancer Inst. 91,143 -151.[CrossRef][Medline]
Tomlinson, I. P., Alam, N. A., Rowan, A. J., Barclay, E., Jaeger, E. E., Kelsell, D., Leigh, I., Gorman, P., Lamlum, H., Rahman, S. et al. (2002). Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat. Genet. 30,406 -410.[Medline]
Uchida, T., Rossignol, F., Matthay, M. A., Mounier, R., Couette,
S., Clottes, E. and Clerici, C. (2004). Prolonged hypoxia
differentially regulates HIF-1alpha AND HIF-2alpha expression in lung
epithelial cells: Implication of HIF-1alpha natural antisense. J.
Biol. Chem. 279,14871
-14878.
Unruh, A., Ressel, A., Mohamed, H. G., Johnson, R. S., Nadrowitz, R., Richter, E., Katschinski, D. M. and Wenger, R. H. (2003). The hypoxia-inducible factor-1alpha is a negative factor for tumor therapy. Oncogene 22,3213 -3220.[CrossRef][Medline]
Vaux, E. C., Metzen, E., Yeates, K. M. and Ratcliffe, P. J.
(2001). Regulation of hypoxia-inducible factor is preserved in
the absence of a functioning mitochondrial respiratory chain.
Blood 98,296
-302.
Wang, G. L., Jiang, B. H. and Semenza, G. L. (1995a). Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 212,550 -556.[CrossRef][Medline]
Wang, G. L., Jiang, B. H. and Semenza, G. L. (1995b). Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 216,669 -675.[CrossRef][Medline]
Wang, G. L. and Semenza, G. L. (1995).
Purification and characterization of hypoxia-inducible factor 1. J.
Biol. Chem. 270,1230
-1237.
Wartenberg, M., Ling, F. C., Muschen, M., Klein, F., Acker, H.,
Gassmann, M., Petrat, K., Putz, V., Hescheler, J. and Sauer, H.
(2003). Regulation of the multidrug resistance transporter
P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor
(HIF-1) and reactive oxygen species. FASEB J.
17,503
-505.
Weissmann, N., Tadic, A., Hanze, J., Rose, F., Winterhalder, S., Nollen, M., Schermuly, R. T., Ghofrani, H. A., Seeger, W. and Grimminger, F. (2000). Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase-derived H(2)O(2)? [In Process Citation]. Am. J. Physiol. 279,L683 -L690.
Welsh, S. J., Bellamy, W. T., Briehl, M. M. and Powis, G.
(2002). The redox protein thioredoxin-1 (Trx-1) increases
hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression
results in increased vascular endothelial growth factor production and
enhanced tumor angiogenesis. Cancer Res.
62,5089
-5095.
Wenger, R. H. (2002). Cellular adaptation to
hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible
transcription factors, and O2-regulated gene expression.
FASEB J. 16,1151
-1162.
Wick, A., Wick, W., Waltenberger, J., Weller, M., Dichgans, J.
and Schulz, J. B. (2002). Neuroprotection by hypoxic
preconditioning requires sequential activation of vascular endothelial growth
factor receptor and Akt. J. Neurosci.
22,6401
-6407.
Wiener, C. M., Booth, G. and Semenza, G. L. (1996). In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 225,485 -488.[CrossRef][Medline]
Wiesener, M. S., Jurgensen, J. S., Rosenberger, C., Scholze, C.
K., Horstrup, J. H., Warnecke, C., Mandriota, S., Bechmann, I., Frei, U. A.,
Pugh, C. W. et al. (2003). Widespread hypoxia-inducible
expression of HIF-2alpha in distinct cell populations of different organs.
FASEB J. 17,271
-273.
Wiesener, M. S., Turley, H., Allen, W. E., Willam, C., Eckardt,
K. U., Talks, K. L., Wood, S. M., Gatter, K. C., Harris, A. L., Pugh, C. W.,
Ratcliffe, P. J. and Maxwell, P. H. (1998). Induction of
endothelial PAS domain protein-1 by hypoxia: characterization and comparison
with hypoxia-inducible factor-1alpha. Blood
92,2260
-2268.
Wilson, D. F., Mokashi, A., Chugh, D., Vinogradov, S., Osanai, S. and Lahiri, S. (1994). The primary oxygen sensor of the cat carotid body is cytochrome a3 of the mitochondrial respiratory chain. FEBS Lett. 351,370 -374.[CrossRef][Medline]
Wong, P. C., Cai, H., Borchelt, D. R. and Price, D. L. (2002). Genetically engineered mouse models of neurodegenerative diseases. Nat. Neurosci. 5, 633-639.[CrossRef][Medline]
Yan, S. F., Lu, J., Zou, Y. S., Soh-Won, J., Cohen, D. M.,
Buttrick, P. M., Cooper, D. R., Steinberg, S. F., Mackman, N., Pinsky, D. J.
and Stern, D. M. (1999). Hypoxia-associated induction of
early growth response-1 gene expression. J. Biol.
Chem. 274,15030
-15040.
Zagzag, D., Nomura, M., Friedlander, D. R., Blanco, C. Y., Gagner, J. P., Nomura, N. and Newcomb, E. W. (2003). Geldanamycin inhibits migration of glioma cells in vitro: a potential role for hypoxia-inducible factor (HIF-1alpha) in glioma cell invasion. J. Cell Physiol. 196,394 -402.[CrossRef][Medline]
Zagzag, D., Zhong, H., Scalzitti, J. M., Laughner, E., Simons, J. W. and Semenza, G. L. (2000). Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88,2606 -2618.[CrossRef][Medline]
Zhang, S. X., Gozal, D., Sachleben, L. R., Jr, Rane, M., Klein,
J. B. and Gozal, E. (2003). Hypoxia induces an
autocrine-paracrine survival pathway via platelet-derived growth factor
(PDGF)-B/PDGF-beta receptor/phosphatidylinositol 3-kinase/Akt signaling in
RN46A neuronal cells. FASEB J.
17,1709
-1711.
Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C.,
Georgescu, M. M., Simons, J. W. and Semenza, G. L. (2000).
Modulation of hypoxia-inducible factor 1alpha expression by the epidermal
growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human
prostate cancer cells: implications for tumor angiogenesis and therapeutics.
Cancer Res. 60,1541
-1545.
Zhou, J., Schmid, T., Frank, R. and Brune, B.
(2004). PI3K/Akt is required for heat shock proteins to protect
HIF-1alpha from pVHL-independent degradation. J. Biol.
Chem. 279,13506
-13513.
Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B. et al. (2000). Loss of PTEN facilitates HIF-1-mediated gene expression. Genet. Dev. 14,391 -396.
Related articles in JEB: